Canada Urged to Lower Cancer Screening Age Amid Rise in Young Adults

OTTAWA, ON – March 11, 2026 – A major public health alarm is sounding across Canada as the Canadian Cancer Society (CCS) today issued an urgent call for provinces and territories to lower the starting age for colorectal cancer screening from 50 to 45. The plea comes in response to what experts describe as a silent but rapidly growing epidemic of the disease among younger Canadians.

Colorectal cancer, the second deadliest cancer in the country, is increasingly being diagnosed in people who fall outside the current screening window. This policy gap, advocates argue, is leaving a generation vulnerable at a time when early detection could save thousands of lives.

"Current colorectal cancer screening guidelines are failing to meet the evolving needs of people under 50," said Brandon Purcell, Advocacy Manager of Prevention and Early Detection at the Canadian Cancer Society. "When the context changes, our healthcare systems must change with it. We are urging provinces and territories to respond to this evidence by lowering the screening age. This change will save more lives."

A Disturbing Trend

Behind the call for action is a wealth of stark and unsettling data. Research shows that over the last few decades, the incidence of colorectal cancer in Canadians under 50 has skyrocketed, with individuals in this age group now facing a risk two to two-and-a-half times higher than previous generations at the same age. The risk for an average 45-year-old today is now comparable to that of a 50-year-old in the late 1970s, when screening was first widely recommended.

Compounding the issue is the fact that younger adults are more frequently diagnosed at advanced stages, when the cancer has already spread. While the five-year survival rate for colorectal cancer is about 90% when caught early, it plummets to less than 15% when discovered at stage IV. This makes access to timely screening not just beneficial, but critical.

"What makes the rise in colorectal cancer among younger adults so alarming isn't just the trend in the data. It's what that trend represents for real people," said Dr. Darren Brenner, a professor and researcher at the University of Calgary. "We're seeing more Canadians diagnosed at ages when cancer is least expected, often before routine screening begins."

The Human Cost of Waiting

For Wylie Butler, the statistics became a harsh reality. An active father of two, he was diagnosed with colorectal cancer at 48, two years before he would have been eligible for screening under current guidelines. For months, he had dismissed occasional bleeding as a minor issue.

"I never thought colorectal cancer was something that could happen to me," Wylie shared. "I didn't realize how serious those early symptoms were. If screening had started at 45, my cancer might have been found sooner and I could have avoided some of the complications I went through."

By the time he sought medical care, the cancer had progressed significantly, leading to three surgeries, a life-threatening bout of sepsis, and months away from his work and family. Now cancer-free, Wylie's story is a powerful testament to the human cost of delayed diagnosis.

"I got lucky, but we shouldn't rely on luck," he said. "Screening at an earlier age gives people the chance to find colorectal cancer before symptoms appear. And when it's found early, you have better odds – and a better chance at life."

The Scientific Case for Change

The push to lower the screening age is not just an emotional appeal; it is backed by robust scientific and economic modeling. A landmark Canadian study published just this week in the Journal of the Canadian Association of Gastroenterology projects that lowering the screening age to 45 could prevent over 15,000 cases of colorectal cancer and avert 6,100 deaths over the next 45 years.

Furthermore, the study suggests the move would be economically prudent. While expanding screening would incur upfront costs for more at-home fecal immunochemical tests (FIT) and follow-up colonoscopies, the researchers calculated it would result in a net saving of $233 million for the healthcare system. These savings would come from avoiding the immense costs of treating advanced-stage cancers.

Canada would not be the first to make this change. The United States officially lowered its recommended screening age to 45 in 2021, following a similar move by the American Cancer Society in 2018. Australia also reduced its screening age to 45 in 2024, signaling a global consensus on the need to adapt to the changing epidemiology of the disease.

A Patchwork of Provincial Action

Despite the mounting evidence, Canada's response remains fragmented. Currently, almost all provinces and territories offer organized screening programs for average-risk individuals aged 50 to 74. However, no government has yet committed to lowering the age to 45.

Quebec remains an outlier, being the only province without an organized, population-based screening program. Elsewhere, responses to the new evidence are mixed. Nova Scotia has indicated it is considering a change, while Saskatchewan has stated it is not. This patchwork approach means a Canadian’s access to potentially life-saving screening can depend on their postal code.

Advocacy groups stress that simply lowering the age is not enough. "Governments must fully implement and adequately fund organized screening programs and ensure that at least 60% of the eligible population participates in screening in a timely manner," said Barry D. Stein, President and CEO of Colorectal Cancer Canada. "This requires strengthening system capacity, investing in research, improving pan-Canadian data collection, and aligning evidence-based screening guidelines across the country."

Can the System Cope?

The primary hurdle to implementing this change is healthcare system capacity. Expanding eligibility to the 45-49 age group would add a significant number of people to screening rosters, increasing demand for FIT kits and, more critically, for follow-up colonoscopies—a procedure for which many provinces already have long wait times. The Canadian Cancer Society acknowledges this challenge, urging governments to invest in the healthcare workforce and infrastructure needed to meet the increased demand without compromising access for other age groups.

"Making [screening programs] more accessible for more people by lowering the screening age is a crucial next step," said Purcell. "Now governments need to react swiftly and adjust course, ensuring programs have the capacity needed to meet increased demand."

All eyes will be on the Canadian Task Force on Preventive Health Care, which is set to relaunch in April 2026 after its last guidelines were issued a decade ago. The medical community and patient advocates will be watching closely to see if the national body will update its recommendations to reflect the new and urgent reality of colorectal cancer in Canada.